Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation. Read more about Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation.
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Read more about Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency. Read more about Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
Harnessing regulatory T cells to establish immune tolerance. Read more about Harnessing regulatory T cells to establish immune tolerance.
TREM1 activation of myeloid cells promotes antitumor immunity. Read more about TREM1 activation of myeloid cells promotes antitumor immunity.
The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC-derived sensory neurons. Read more about The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC-derived sensory neurons.
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Read more about Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. Read more about Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies.
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis. Read more about Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.
Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans. Read more about Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans.
